Regencell Bioscience Holdings Ltd. (RGC) News

Regencell Bioscience Holdings Ltd. (RGC): $22.50

0.00 (0.00%)

POWR Rating

Component Grades








Add RGC to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals




#129 of 171

in industry

Filter RGC News Items

RGC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest RGC News From Around the Web

Below are the latest news stories about REGENCELL BIOSCIENCE HOLDINGS LTD that investors may wish to consider to help them evaluate RGC as an investment opportunity.

One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 0.5% in the previous year

Looking at Regencell Bioscience Holdings Limited's ( NASDAQ:RGC ) insider transactions over the last year, we can see...

Yahoo | April 3, 2023

With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future

Key Insights Insiders appear to have a vested interest in Regencell Bioscience Holdings' growth, as seen by their...

Yahoo | February 21, 2023

Companies Like Regencell Bioscience Holdings (NASDAQ:RGC) Are In A Position To Invest In Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Yahoo | November 21, 2022

RGC: Forging a New Approach to ADHD and ASD

By Brad Sorensen, CFA NASDAQ:RGC Traditional “western” medicine has made amazing advances and is one of the great innovations in history, but, unfortunately, there are still many conditions afflicting people that western medicine hasn’t been able to treat with any great effectiveness. It’s in instances like these that it can be beneficial to look to a medical approach that’s been around for over

Yahoo | November 15, 2022

One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 1.4% in the previous year

Insiders were net buyers of Regencell Bioscience Holdings Limited's ( NASDAQ:RGC ) stock during the past year. That is...

Yahoo | October 25, 2022

81% of Regencell Bioscience Holdings Limited (NASDAQ:RGC) is owned by insiders, and they've been buying recently

Every investor in Regencell Bioscience Holdings Limited ( NASDAQ:RGC ) should be aware of the most powerful shareholder...

Yahoo | September 14, 2022

Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial

HONG KONG, September 12, 2022--Regencell Bioscience Holdings Limited (Nasdaq: RGC) ("Regencell") today announced its interim results from its second efficacy trial.

Yahoo | September 12, 2022

RGC: CEO Figuratively Putting His Money Where His Mouth Is

By Beth Senko, CFA NASDAQ:RGC Investors have faced challenging and volatile markets so far in 2022 as they sort through issues of inflation, supply chain disruption, continued covid issues, rising interest rates, and the disruption of the war in Ukraine. The S&P 500 has come close to bear market levels, down 19% in mid-June. Times of turbulence affect all stocks, large and small. It can be

Yahoo | June 20, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.664 seconds.